You are viewing: Mexico Biopreservation Market analysis
Part of: Biopreservation Market (Global)

The Mexico Biopreservation Market was valued at $35 Million in 2024 and projected to reach to $53 Million by 2029, representing a compound annual growth rate of 8.7%. Mexico's biopreservation market is poised for significant expansion as healthcare modernization initiatives and increased pharmaceutical R&D investments drive demand for advanced preservation solutions.

Mexico Biopreservation Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Mexico Biopreservation Market Trends and Insights

  • This expansion in Mexico reflects increasing adoption of advanced preservation technologies across healthcare institutions, research facilities, and pharmaceutical companies operating within the country.
  • Mexico's biopreservation sector is driven by rising demand for cell and tissue banking, regenerative medicine applications, and improved cold chain infrastructure. The Mexican biopreservation market benefits from growing investment in life sciences research and development, coupled with regulatory improvements that facilitate the adoption of preservation technologies.
  • Mexico's strategic position in Latin America and its expanding biopharmaceutical sector create opportunities for market participants.
  • Between 2024 and 2029, Mexico is expected to see accelerated adoption of cryopreservation and other biopreservation solutions, supported by healthcare modernization initiatives and increased collaboration with international research institutions..

Key Market Statistics

  • CAGR (2024-2029) 8.7% CAGR
  • Market Size, 2024 ~USD 35 Million
  • Forecast, 2029 ~USD 53 Million
  • Country Mexico

Mexico Biopreservation Market Overview

Market Valuation :

Mexico's biopreservation market is valued at $35.0 million in 2024, with strong growth trajectory positioning it as a key market in Latin America's healthcare preservation sector.

Growth Momentum :

The market is expanding at a CAGR of 8.7% through 2029, outpacing many emerging markets and reflecting Mexico's increasing investment in advanced healthcare infrastructure and research capabilities.

Technology Adoption :

Mexican healthcare institutions, research facilities, and pharmaceutical companies are rapidly adopting advanced biopreservation technologies, driven by regulatory improvements and rising demand for cell and tissue banking.

Forecast Growth :

The market is projected to reach $53.0 million by 2029, representing an 51% increase over five years and demonstrating sustained confidence in Mexico's biopreservation sector expansion.

Mexico Biopreservation Market Dynamics

  • The country's growing biotechnology sector, coupled with rising adoption of regenerative medicine and cell therapy applications, creates substantial opportunities for market participants.
  • Government support for healthcare infrastructure development and the presence of major pharmaceutical manufacturing hubs further accelerate market penetration. Looking ahead, Mexico's biopreservation market will benefit from enhanced regulatory frameworks, increased collaboration with international research institutions, and growing awareness of biobanking importance.
  • The expansion of clinical research facilities and the rising prevalence of chronic diseases requiring advanced treatment options will continue to fuel demand.
  • Strategic partnerships between local healthcare providers and global biopreservation technology leaders are expected to accelerate market maturation through 2029..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • Mexico's biopreservation market is valued at $35.0 million in 2024 and is forecast to reach $53.0 million by 2029.
    • Mexico is experiencing an 8.7% compound annual growth rate, driven by increased adoption of cell and tissue banking technologies.
    • Mexico's biopreservation sector is supported by growing pharmaceutical R&D investment and healthcare infrastructure modernization.
    • Mexico's strategic regional position and expanding biopharmaceutical industry create significant opportunities for market expansion through 2029.

    Biopreservation Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment BIOPRESERVATION EQUIPMENT (Product)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.8% from 2024 to 2029
    Largest Segment BIOPRESERVATION MEDIA (Product)
    Market Size Base Year (Billions) ~USD 4.45 (2024)
    Revenue Forecast (Billions) ~USD 7.1 (2029)
    Segments Covered Product, Type, Biospecimen, Application, End User, Transplant Type

    Mexico Biopreservation Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Biopreservation Accessories
    • Biopreservation Equipment
    • Biopreservation Media

    By Type

    • Alarm Monitoring Systems
    • Centrifuges
    • Cryogenic Storage Systems
    • Cryopreservation Media
    • Freezers
    • Hypothermic Preservation Media
    • Incubators
    • Other Biopreservation Equipment
    • Other Equipment
    • Refrigerators
    • Temperature Control Systems
    • Thawing Equipment

    By Biospecimen

    • Human Tissue Samples
    • Organs
    • Other Biospecimens
    • Stem Cells

    By Application

    • Other Applications
    • Research Applications
    • Therapeutic Applications

    By End User

    • Biobanks
    • Gene Banks
    • Hospitals
    • Other End Users

    By Transplant Type

    • Cord Blood Transplants
    • Organ Transplants

    MEXICO: BIOPRESERVATION MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    BIOBANKS27.2628.7231.6733.1637.2439.9843.5348.128.7
    GENE BANKS17192022232527297.7
    HOSPITALS19212224262830327.8
    OTHER END USERS891011111213147
    TOTAL71.2677.7283.6790.1697.24104.98113.53123.128

    Target Audience

    • Biopreservation Technology Providers : Equipment manufacturers and solution providers need Mexico-specific market data to assess demand potential, identify customer segments, and develop localized product strategies for this expanding healthcare market.
    • Pharmaceutical & Biotech Companies : Organizations operating in Mexico require detailed market insights to optimize R&D investments, plan facility expansions, and identify opportunities in cell therapy and regenerative medicine applications.
    • Healthcare Facility Operators : Hospital networks and research institutions in Mexico need market intelligence to justify biopreservation infrastructure investments, benchmark against peers, and plan technology adoption roadmaps.
    • Investment & Private Equity Firms : Investors evaluating opportunities in Mexico's healthcare sector require comprehensive market data to assess growth potential, valuation benchmarks, and risk-adjusted returns in biopreservation ventures.
    • Regulatory & Policy Advisors : Consultants and policy organizations need Mexico-specific market analysis to understand industry trends, inform regulatory development, and guide healthcare modernization initiatives in the biopreservation sector.

    Reasons to Buy this Report

    • Market Entry Strategy : Gain comprehensive insights into Mexico's biopreservation landscape to develop targeted market entry strategies, identify key stakeholders, and understand competitive positioning within this high-growth Latin American market.
    • Investment Decision Support : Access detailed financial projections and growth metrics specific to Mexico to support investment decisions, funding allocation, and resource planning for biopreservation ventures in the region.
    • Competitive Intelligence : Understand Mexico's unique market dynamics, regulatory environment, and technology adoption patterns to benchmark against competitors and identify differentiation opportunities in this emerging market.
    • Partnership Identification : Identify potential partners, distributors, and collaboration opportunities within Mexico's healthcare institutions, research facilities, and pharmaceutical companies operating in the biopreservation space.
    • Risk Mitigation : Evaluate market-specific risks, regulatory requirements, and operational challenges in Mexico to develop informed strategies that minimize uncertainties and maximize success probability in this growing market.

    Frequently asked questions

    What is the current size of Mexico's biopreservation market?

    Mexico's biopreservation market was valued at $35.0 million in 2024 and is expected to grow to $53.0 million by 2029.

    What is the growth rate of Mexico's biopreservation market?

    Mexico's biopreservation market is growing at a compound annual growth rate of 8.7% from 2024 to 2029.

    What are the main drivers of growth in Mexico's biopreservation market?

    Key drivers in Mexico include increased demand for cell and tissue banking, expansion of regenerative medicine applications, improved cold chain infrastructure, and growing pharmaceutical R&D investment.

    Which sectors are driving biopreservation adoption in Mexico?

    Mexico's biopreservation adoption is driven by healthcare institutions, research facilities, pharmaceutical companies, and regenerative medicine centers seeking advanced preservation solutions.

    How does Mexico's biopreservation market compare to the global market?

    Mexico's 8.7% CAGR is slightly below the global average of 9.8%, reflecting regional market maturity and growth potential within Latin America.

    RESEARCH METHODOLOGY

    The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the Biopreservation market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

    The four steps involved in estimating the market size are:

    Collecting Secondary Data

    The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Biopreservation market. A database of the key industry leaders was also prepared using secondary research.

    Collecting Primary Data

    The primary research data was conducted after acquiring knowledge about the Biopreservation market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as biobanks, gene banks, hospitals, and academic research institute) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and GCC. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

    A breakdown of the primary respondents is provided below:

    Breakdown of Primary Participants:

    Biopreservation Market Size, and Share

    Note 1: *Others include sales managers, marketing managers, and product managers.

    Note 2: Tiers are defined based on a company’s total revenue as of 2023: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    All major product manufacturers offering various Biopreservation were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value Biopreservation market was also split into various segments and subsegments at the region and country level based on:

    • Product mapping of various manufacturers for each type of Biopreservation market at the regional and country-level 
    • Relative adoption pattern of each Biopreservation market among key application segments at the regional and/or country-level 
    • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level. 
    • Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level 

    Global Biopreservation Market Size: Top Down Approach

    Biopreservation Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Global Biopreservation Market Size: Bottom-Up Approach

    Biopreservation Market Size, and Share

    Data Triangulation

    After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Biopreservation industry.

    Market Definition

    Biopreservation is a technique used for the storage of cells and tissues in a hypothermic or chemical environment to preserve biological samples with sustained integrity. The different types of biospecimen stored include human tissue samples, stem cells, and organs, which are majorly used in therapeutic and research applications. These high-yielding cell lines need to be preserved in order to provide optimum yield, viability, and productivity, which can be achieved by cryopreservation and vitrification in a hypothermic storage environment. Biopreservation is a rapidly emerging field of specimen procurement, processing, preservation and banking which requires a close collaboration between clinicians, engineers and scientists coming from academia, small private enterprises or huge industrial companies.

    Key Stakeholders

    • Senior Management
    • Finance/Procurement Department
    • Doctors/HCPs
    • Researchers
    • Lab Managers/Technicians
    • End Users/Operators

    Report Objectives

    • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To define, describe, segment, and forecast the Biopreservation market by product, biospecimen, application, end user, and region.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall Biopreservation market
    • To forecast the size of the Biopreservation market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, Middle East & Africa, and GCC.
    • To profile key players in the Biopreservation market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the Biopreservation market.
    • To benchmark players within the Biopreservation market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

    Available Customizations

    MarketsandMarkets offers the following customizations for this market report:

    • Additional country-level analysis of the Biopreservation market
    • Profiling of additional market players (up to 5)

    Product Analysis

    • Product matrix, which provides a detailed comparison of the product portfolio of each company in the Biopreservation Market

    Get the Full Biopreservation Market Report

    Full forecast, segment splits, and company analysis for all Biopreservation Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status